The unique device identifier (udi) is unknown because the part and lot numbers were not provided.The device was not returned for evaluation.A review of the lot history record and complaint history could not be conducted because the part and lot number was not provided.The reported patient effect of thrombosis and myocardial infarction are listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use as known adverse events associated with the use of a coronary scaffold in native coronary arteries.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2016, an absorb scaffold was implanted in an unspecified artery.Two days post scaffold implantation, the patient experienced a myocardial infarction and in-stent thrombosis was noted.No additional information regarding this issue was provided.
|